S.-H. Yoon et al. / Carbohydrate Research 339 (2004) 1517–1529
1529
5. Arakawa,H.; Funayama,M.; Yamamoto,R.; Nishino,T.
respectively,and the transfer of D-glucopyranose from
sucrose to the nonreducing end of the isomaltose unit of
Jpn. Kokai Tokkyo Koho 06284897, 1994.
6. Shimoide,A.; Watanabe,M.; Donho,M.
Tokkyo Koho 08173183, 1996.
Jpn. Kokai
a-isomaltoisosalicin to form an a-(1 ! 2) glycosidic
linkage to give 2II-(a-
-glucopyranosyl)-a-isomaltoiso-
D
7. Okano,Y.; Masaki,H.; Ogawa,A.
Koho 11116426, 1999.
Jpn. Kokai Tokkyo
salicin (Fig. 3I). In addition to these a-isosalicin ana-
logues,B-742CB dextransucrase also formed minor
€
8. Schmid,B.; K otter,I.; Heide,L. Eur. J. Pharmacol. 2001,
57,387–391.
9. French,D. Adv. Carbohydr. Chem. 1957, 12,225–231.
10. Robyt,J. F. Adv. Carbohydr. Chem. Biochem. 1995, 51,
151–162.
amounts of a-salicin and transferred
from sucrose to form an a-(1 ! 6) linkage to the
D-glucopyranose
D
-
glucopyranosyl moiety of a-salicin to give 1-a-isomal-
tosyl salicyl alcohol or a-isomaltosalicin (Fig. 3F).
It is known that the major active metabolite from b-
salicin in serum is salicylic acid.3;7 b-Salicin is absorbed
only to a small extent in the small intestine after oral
administration.3 It is hydrolyzed to salicyl alcohol,
which is readily absorbed from the small intestine by the
action of b-glycosidases secreted by the intestinal mi-
croflora3;33–35 or by b-galactosidase in the mucous
membrane of the small intestine.35 The absorbed salicyl
11. Kobayashi,S.; Kainuma,K.; Suzuki,S.
1978, 61,229–238.
Carbohydr. Res.
12. Lee,S.-B.; Robyt,J. F. Carbohydr. Res. 2001, 336,47–53.
13. Yoon,S.-H.; Robyt,J. F.
2427–2435.
Carbohydr. Res. 2002, 337,
14. Kitaoka,M.; Robyt,J. F. Enzyme Microb. Technol. 1998,
23,386–391.
15. Yoon,S.-H.; Mukerjea,R.; Robyt,J. F. Carbohydr. Res.
2003, 338,1127–1132.
16. Robyt,J. F. Thin-layer Chromatography of Carbohy-
drates. In Encyclopedia of Separation Science; Wilson,I.
D.,Cooke,M.,Poole,C. F.,Eds.; Academic: New York,
2000; Vol. 5,pp 2235–2244.
alcohol is rapidly oxidized to salicylic acid in the human
36;37
organs (liver,kidney,and lung) of the body.
Con-
17. Robyt,J. F.; Mukerjea,R. Carbohydr. Res. 1994, 251,
187–202.
18. Fox,J. D.; Robyt,J. F. Anal. Biochem. 1991, 195,93–96.
19. Robyt,J. F.; White,B. J. Biochemical Techniques––Theory
and Practice; Waveland: Prospect Heights,IL,1990; pp
82–86 and 106–111.
sequently,when b-salicin is taken orally,it is poorly
absorbed,but it is slowly transformed into salicyl alco-
hol by intestinal bacteria,and the absorbed salicyl
alcohol is oxidized to the active metabolite,salicylic
acid.
20. Kazmaier,T.; Toth,S.; Zapp,J.; Harding,M.; Kuhn,R.
Fresenius J. Anal. Chem. 1998, 361,473–478.
21. Bock,K.; Pedersen,C. H. J. Carbohydr. Chem. 1984, 3,
581–592.
22. Duus,J. Ø.; Gotfredsen,C. H.; Bock,K. Chem. Rev. 2000,
100,4589–4614.
23. Yoon,S.-H.; Robyt,J. F. Carbohydr. Res. 2002, 337,509–
516.
24. Tamaki,A.; Ide,T.; Otsuka,H. J. J. Nat. Prod. 2000, 63,
1417–1419.
Although it has not yet been demonstrated,it might
be expected that a-salicin and its analogues, a-isosalicin,
a-nigerosalicin, a-maltosalicin,and a-isomaltosalicin
that have been synthesized in this study,would be
readily hydrolyzed by the a-glucosidases secreted by the
brush border cells that line the small intestinal wall.38
This would then facilitate the absorption of salicyl
alcohol and would make it a mild but effective antipy-
retic and analgesic prodrug with none of the gastric in-
jury and side effects that have been ascribed to aspirin
(sodium acetylsalicylate).
In conclusion,two types of salicin prodrugs have been
enzymatically synthesized. The reaction of B. macerans
CGTase with cyclomaltohexaose and salicyl alcohol
gave a-salicin as a major product and the reaction of
L. mesenteroides B-742CB dextransucrase with sucrose
and salicyl alcohol gave a-isosalicin as the major prod-
uct.
25. Itoh,A.; Tanahashi,T.; Inoue,K.; Kuwajima,H.; Wu,
H.-X. Chem. Pharm. Bull. 2001, 49,1343–1345.
26. Bock,K.; Thøgersen,H. Annu. Rep. NMR Spectro. 1982,
13,1–57.
27. Vetere,A.; Gamini,A.; Campa,C.; Paoletti,S.
Biophys. Res. Commun. 2000, 274,99–104.
Biochem.
28. Hoffman,R. E.; Christofides,J. C.; Davies,D. B.;
Lawson,C. J. Carbohyr. Res. 1986, 153,1–16.
29. Jarrell,H. C.; Conway,T. F.; Moyna,P.; Smith,I. C. P.
Carbohydr. Res. 1979, 76,45–57.
30. Thompson,J.; Robrish,S. A.; Pikis,A.; Brust,A.;
Lichtenthaler,F. W. Carbohydr. Res. 2001, 331,149–161.
31. Underkofler,L. A.; Denault,L. J.; Hou,E. F.
1965, 17,179–184.
St€arke
32. Zivko,L. N.; Meagher,M. M.; Reilly,P. J.
Bioeng. 1989, 34,694–704.
Biotechnol.
References
33. Mallett,A. K.; Bearne,C. A.; Rowland,I. R.; Farthing,
M. J. G.; Cole,C. B.; Fuller,R. J. Appl. Bacteriol. 1987,
63,39–45.
1. Robyt,J. F. Essentials of Carbohydrate Chemistry; Spring-
er: New York,1998; pp 64–68.
ꢀ
2. Kren,V. Chemical Biology and Biomedicine of Glycosy-
34. Underkofler,L. A.; Denault,L. J.; Hou,E. F.
1965, 17,179–184.
35. Zivko,L. N.; Meagher,M. M.; Reilly,P. J.
Bioeng. 1989, 34,694–704.
36. Fotsch,G.; Pfeifer,S. Pharmazie 1989, 44,710–712.
St€arke
lated Natural Compounds. In Glycoscience: Chemistry and
Chemical Biology; Fraser-Reid,B.,Tatsuta,K.,Thiem,J.,
Eds.; Springer: Berlin,2001; Vol. III,pp 2471–2529.
Biotechnol.
3. Akao,T.; Yoshino,T.; Kobashi,K.; Hattori,M.
Med. 2002, 68,714–718.
Planta
€
37. Steinegger,E.; H ovel,H. Pharm. Acta Helv. 1972, 47,222–234.
4. Matito,C.; Mastorakou,F.; Centelles,J. J.; Torres,J. L.;
Cascante,M. Eur. J. Nutr. 2003, 42,43–49.
38. Gray,G. M.; Lally,B. C.; Conklin,K. A. J. Biol. Chem.
1978, 254,6038–6042.